Adragos Pharma
↗Munich, Germany
Adragos Pharma is a globally operating Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, Germany. Founded in 2020, the company has rapidly become one of the fastest-growing players in the pharmaceutical outsourcing space through a strategic 'buy-and-build' model, acquiring high-quality manufacturing sites from major pharmaceutical companies such as Sanofi and Fresenius Kabi.
The company provides end-to-end services ranging from early-stage formulation development to large-scale commercial manufacturing. Its global network specializes in a wide array of dosage forms, including sterile liquids (ampoules, vials, IV bags), oral solids, semi-solids, and Blow-Fill-Seal (BFS) technology. Adragos emphasizes a customer-centric, 'service-first' philosophy and is actively integrating digital innovations, such as AI-driven customer portals, to modernize the CDMO experience.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:CDMO (Contract Development and Manufacturing)
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Investors:FSN Capital (Majority), Prange Group, Dr. Andreas Raabe
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics (Fill-Finish), Sterile liquids, Oral solids, Semi-solids, Blow-Fill-Seal (BFS), Lyophilization
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Baccinex (Switzerland), Lamda Laboratories (Greece), Adragos Livron (France), Adragos Leipzig (Germany), Adragos Kawagoe (Japan), Adragos Halden (Norway)
Key Partnerships:Sanofi (Long-term supply agreement for the Japanese market), Fresenius Kabi (Site acquisition and supply partnership in Norway), Clinigen (Acquisition of development engine Lamda Laboratories)
COMPETITION
Position:Challenger
Competitors:Recipharm, Aenova Group, Delpharm, Fareva, Siegfried Holding, CordenPharma, Catalent, Lonza
LEADERSHIP
Key Executives:
Dr. Andreas Raabe - CEO & Founder
Henny Zijlstra - Chief Commercial Officer (CCO)
Marco Gorgas - Chief Operating Officer (COO)
Scientific Founders:Dr. Andreas Raabe
Board Members:Representatives from FSN Capital, Representatives from Prange Group
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Adragos Pharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.